CSP Inc. 10-Q Summary: Period Ended May 31, 1996
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended May 31, 1996, and the nine-month period ended May 31, 1996, for CSP Inc. The company operates through three primary divisions: CSP (Embedded Computing), Scanalytics (bio-instrumentation), and Vision Systems. The fiscal year ends on the last Friday in August; fiscal year 1996 is a 53-week year.
Key Financial Metrics
| Metric | 3 Months Ended May 31, 1996 | 9 Months Ended May 31, 1996 |
|---|---|---|
| Sales | $4,007,000 | $12,392,000 |
| Net Income (Loss) | ($167,000) | ($82,000) |
| Operating Income (Loss) | ($536,000) | ($770,000) |
| Gross Margin | 55% | 58% |
| Cash and Cash Equivalents | $10,559,000 | $10,559,000 |
| Working Capital | $22,822,000 | $22,822,000 |
| Debt | None reported | None reported |
| Net Cash from Operating Activities | $733,000 | $930,000 |
Material Changes vs. Prior Period
- Revenue Decline: Sales decreased 16% ($768,000) for the quarter and 13% ($1,750,000) for the nine-month period compared to fiscal 1995.
- Profitability Shift: The company moved from a net profit of $320,000 (quarter) and $28,000 (nine months) in the prior year to net losses of $167,000 and $82,000, respectively.
- Division Performance:
- CSP Division: Sales declined 21% (quarter) and 10% (nine months) due to reduced shipments of older products (MAP-4000, MiniMap, RTS), though the Supercard family increased its sales mix share.
- Scanalytics Division: Sales increased due to strong CellScan product shipments, offsetting declines in the Ambis product line.
- Vision Systems Division: Sales dropped significantly (77% decline for nine months) due to a lack of significant orders from UPS and other customers for machine code readers.
- Expense Trends: Engineering and development expenses rose 31% (quarter) and 12% (nine months) due to new product development (PowerPC and 21060 upgrades). General and administrative expenses fell 49% (quarter) and 20% (nine months), partially offset by one-time CEO departure charges of approximately $220,000.
Outlook, Risks, and Management Commentary
- Liquidity: Management maintains a conservative investment strategy with a strong liquid position ($10.6M cash + $7.1M marketable securities). No borrowing is required for capital needs.
- Product Strategy: Engineering efforts are increasing significantly over the next four to five quarters to complete new product offerings. Inventory increased $185,000 due to purchases of long-lead time items anticipating fourth-quarter sales.
- Risks: Revenue concentration in North America (90% of YTD sales) and reliance on specific customers (e.g., UPS for Vision Systems) pose risks. Management notes no assurance that inflation will not materially affect future operations.
- Unusual Items: The prior year included $409,000 in restructuring expenses which are absent in the current period. Current G&A includes one-time charges related to the CEO departure.
Investor Verification Checklist
- Verify the sustainability of the Vision Systems division given the 77% year-to-date revenue decline and lack of UPS orders.
- Confirm the timeline and budget for the new PowerPC and 21060 product developments driving increased R&D spend.
- Assess the impact of the CEO departure and the current "Acting" CEO status on strategic execution.
- Monitor inventory levels ($2.3M) against the anticipated fourth-quarter sales to ensure no obsolescence risk.
- Review the geographic sales concentration (90% North America) for potential market exposure risks.